ストックスクリーナーアプリを入手
1.24
24.45%
0.2436
アフターアワーズ：
1.26
0.02
+1.61%
前日終値:
$0.9964
開ける：
$0.8788
24時間の取引高:
944.92K
Relative Volume:
3.91
時価総額：
$50.25M
収益：
$4.14M
当期純損益:
$-3.19M
株価収益率:
-1.6598
EPS:
-0.7471
ネットキャッシュフロー:
$11,000
1週間 パフォーマンス:
+135.72%
1か月 パフォーマンス:
+100.81%
6か月 パフォーマンス:
-17.00%
1年 パフォーマンス:
-44.14%
1日の値動き範囲:
$0.8602
$1.46
1週間の範囲:
$0.3818
$1.46
52週間の値動き範囲:
$0.3818
$2.5977
China Pharma Holdings Inc. Stock (CPHI) Company Profile
名前
China Pharma Holdings Inc.
セクター
電話
86 898 6681 1730
住所
No. 17, Jinpan Road, Second Floor, Haikou
Compare CPHI vs TAK, TEVA, HLN, ZTS, UTHR
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
CPHI
China Pharma Holdings Inc.
|
1.24 | 40.38M | 4.14M | -3.19M | 11,000 | -0.7471 |
TAK
Takeda Pharmaceutical Co Adr
|
16.63 | 52.58B | 29.85B | 776.90M | 4.35B | 0.2408 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
35.31 | 42.21B | 17.53B | 1.58B | 444.18M | 1.3457 |
HLN
Haleon Plc Adr
|
8.91 | 39.99B | 14.54B | 2.22B | 2.58B | 0.4871 |
ZTS
Zoetis Inc
|
75.48 | 31.17B | 9.51B | 2.64B | 2.14B | 6.0361 |
UTHR
United Therapeutics Corp
|
575.79 | 24.60B | 3.17B | 1.29B | 1.01B | 27.09 |
China Pharma Holdings Inc. Stock (CPHI) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2010-01-08 | 開始されました | Rodman & Renshaw | Mkt Outperform |
China Pharma Holdings Inc. (CPHI) 最新ニュース
China Pharma Holdings, Inc. States It Knows of No Events That Could Have Caused Unusual Market Activity - digitalmore.co
China Pharma says unaware of reason for unusual trading - Investing.com
China Pharma Holdings IncNYSE American contacts China Pharma regarding unusual market activity on May 12 and 13 - marketscreener.com
China drugmaker sees unusual stock activity, reports no new info - Stock Titan
Unusual volume stocks are being observed in Wednesday's session. - ChartMill
TradingKey - TradingKey
12 Health Care Stocks Moving In Tuesday's After-Market Session - Benzinga
These stocks are moving in today's after hours session - ChartMill
C3 AI Announces Q4 and Fiscal Year 2026 Preliminary Results: Tom Siebel Returns as CEO, Reports Revenue Within Guidance and Improved Operating Losses - Minichart
CPHI Stock Price, Quote & Chart | CHINA PHARMA HOLDINGS INC (NYSEARCA:CPHI) - ChartMill
US Stock Market Trends: Updated Data Analysis & Real-Time Quotes - TradingKey
CPHI PE Ratio & Valuation, Is CPHI Overvalued - Intellectia AI
China NT Pharma Group Quarterly Update on Action Plans for Disclaimer of Opinion Resolution and AI Health Business Transformation 1 - Minichart
Chinese firm Livzon secures control of Vietnam’s pharma giant Imexpharm in $228 mln deal - Theinvestor
Why Seagate Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarket - Benzinga
Unusual VolumeStock ScreenerNews - Finviz
CPHI Technical Analysis & ETF Price Forecast - Intellectia AI
EBITDA per share of China Pharma Holdings, Inc. – AMEX:CPHI - TradingView
EBIT per share of China Pharma Holdings, Inc. – MUN:XQJ0 - TradingView
Regeneron CEO Defends Pharma, Warns China Will ‘Pass Us Right By’ After Announcing Free Gene Therapy For Hearing Loss - Stocktwits
Vertex Pharmaceuticals Incorporated $VRTX Shares Purchased by China Universal Asset Management Co. Ltd. - MarketBeat
Shuttle Pharma (SHPH) proxy asks investors to OK major reverse split range - Stock Titan
China Pharma (CPHI) Stock Dividend Analysis (+1.54%) 2026-04-16Price Action - Cổng thông tin điện tử tỉnh Lào Cai
China Pharma Holdings, Inc. (CPHI) - Minichart
Trading Recap: Does ALLT have strong EBITDA margins2026 Growth vs Value & AI Driven Stock Reports - baoquankhu1.vn
Aug Sentiment: Why is Alexanders Inc stock going downProduct Launch & Weekly High Momentum Picks - baoquankhu1.vn
Is China Pharma (CPHI) Stock a Growth Play | Price at $0.65, Up 0.62%Community Watchlist - newser.com
symbol__ Stock Quote Price and Forecast - CNN
US Market Recap: Can PBHC generate free cash flowLayoff News & Smart Money Movement Alerts - baoquankhu1.vn
Is China Pharma (CPHI) Stock defensive in downturns | Price at $0.60, Down 2.42%Attention Stocks - newser.com
Ascentage Pharma Group International (NASDAQ:AAPG) Raised to "Strong-Buy" at China Intl Cap - MarketBeat
Is Quantum-Si Incorporated (QSI) Stock tied to economic cycles | QSI Q4 Earnings: Beats Estimates by $0.04Sell Rating - Xã Châu Thành
Market Catalysts: Is China Pharma Holdings Incs ROE strong enough2026 Volume Leaders & High Conviction Trade Alerts - baoquankhu1.vn
Earnings Risk: Can China Pharma Holdings Inc expand its profit marginsVolume Spike & Low Drawdown Trading Strategies - baoquankhu1.vn
Can Merchants (MBINL) Stock Beat Estimates | Price at $24.30, Up 1.12%Resistance Breakout - Xã Thanh Hà
China Pharma (NYSE:CPHI) & Acerus Pharmaceuticals (OTCMKTS:ASPCF) Financial Comparison - Defense World
CUPR PE Ratio & Valuation, Is CUPR Overvalued - Intellectia AI
DRMA Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Stock List: Research Stocks from Around the World - GuruFocus
China Pharma Holdings, Inc. (XQJ.DE) Analyst insights, Price targets and Recommendations - Yahoo Finance Singapore
China Pharma Holdings, Inc. (XQJ.DE) Analyst Insights, Price Targets & Recommendations - Yahoo! Finance Canada
CPHI Q3 2011 Earnings: China Pharma Holdings Inc. misses EPS estimates - Cổng thông tin điện tử tỉnh Lào Cai
China Pharma Delays 10-K but Shows Narrowing Losses - The Globe and Mail
China Pharma Holdings 2026 Annual Report: Strategic Focus on Generic Drugs, Market Expansion, and Innovation in China’s Pharmaceutical Industry - Minichart
China Pharma Holdings Files For Non-Timely 10-K With US SEC - TradingView
China Pharma Holdings 10-K: Revenue $4.14M, Loss per Share $(0.74) - TradingView — Track All Markets
China Pharma (NYSE American: CPHI) details 2025 losses and China policy risks - Stock Titan
China Pharma Holdings, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
Buy Signal: Can China Pharma Holdings Inc keep up with sector leadersBull Run & Trade Opportunity Analysis - baoquankhu1.vn
USA Stocks: Research Stocks from USA Stock Market - GuruFocus
US pharma giant reaches $2.75 billion deal with China-based biotech company for AI-developed drugs - Yahoo Finance
China Pharma Holdings Inc. (CPHI) 財務データ
収益
当期純利益
現金流量
EPS
0.73%
3.85%
大文字化:
|
ボリューム (24 時間):